Press Room

News / Nov 14, 2019

Hovione Cork wins the 2019 National Project Awards, Ireland Chapter of PMI

Private Sector Project of the Year

Yesterday, November 14th the winners of the National Project Awards 2019, sponsored by the Ireland Chapter of Project Management Institute were announced.

Hovione Cork received an award for project of the year 2019 in the private sector, for the re-launch of Building 2 located in our manufacturing facility in Ringaskiddy. The award was handed to Alexandre Matos, NPI Project Manager at Hovione Cork.

2019 National Project Awards, Ireland Chapter of PMI | Hovione
Jorge Falcão (Automation Manager) and Alexandre Matos (NPI Project Manager)

 

Learn more at the Ireland Chapter of PMI's website

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025